Search

everythinglearnresearchcommunity

for

Search:↓

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Diuretics can cause serious side effects and should be used carefully.

Panax ginseng might help with hair growth and has fewer side effects than synthetic treatments.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

A girl with symptoms like an autoimmune disorder actually had HIV and a fungal infection, which was hard to diagnose and treat, leading to her death.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Latanoprost is more effective than minoxidil for treating alopecia areata.

Lack of Cisd2 disrupts calcium balance in cells, leading to poorly functioning neutrophils.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Upadacitinib may effectively treat alopecia areata without side effects.

Male gender and family history predict alopecia areata recurrence.

Baricitinib successfully treated severe hair loss.

Essential oils may help hair health but lack strong scientific proof and can cause allergic reactions.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Garudan Kizhangu Ennai may effectively treat alopecia areata but needs more research to confirm its safety and effectiveness.

Antibiotics often cause skin reactions, making them a major health concern.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.